Logotype for SP Group

SP Group (SPG) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for SP Group

Q4 2025 earnings summary

25 Mar, 2026

Executive summary

  • Achieved record Q4 2025 performance, with revenue up nearly 14% and EBITDA up 26% in the quarter, demonstrating resilience despite project postponements and global uncertainties.

  • Full-year revenue grew 0.9% to DKK 2,948 million, with EBITDA margin at 20.2% and EBT margin at 11.7%.

  • Acquired Idé-Pro in December 2025 for DKK 700 million, expected to contribute DKK 450 million in revenue and DKK 100 million in EBITDA, with synergies of DKK 20-25 million by 2027.

  • Expanded U.S. healthcare production with Atlanta factory operational since January 2025 and increased activity in India.

  • Subcontracting work grew almost 6%, while revenue from own products declined by 10% due to project postponements.

Financial highlights

  • Revenue: DKK 2,948 million (+0.9% year-over-year).

  • EBITDA: DKK 595 million (+1.1% year-over-year), margin 20.2%.

  • EBT: DKK 345 million (+0.1% year-over-year), EBT margin 11.7%.

  • Earnings per share, diluted, rose by 2.3% to DKK 22.1.

  • Cash flow from operations: DKK 393 million, down DKK 117 million due to increased inventory.

Outlook and guidance

  • 2026 revenue growth expected at 15%-23%, EBITDA margin 19%-21%, EBT margin 11%-13%.

  • Growth driven by new products, customers, and Idé-Pro acquisition (approx. 15% of growth).

  • Assumes Middle East conflict de-escalates soon; risks from raw material and energy prices acknowledged.

  • Long-term ambition: revenue growth 6%-9% annually to DKK 4.5 billion by 2030, EBT margin 12%-14%.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more